三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01530 三生制药

已收盘 07-25 16:08:07

28.450

-1.950

-6.41%

最高29.700	最低27.400	成交量1.05亿
今开29.350	昨收30.400	日振幅7.57%
总市值682.80亿	流通市值682.80亿	总股本24.00亿
成交额30.03亿	换手率4.37%	流通股本24.00亿
市净率4.04	ROE12.84%	每股收益0.94
52周最高31.447	52周最低5.426	市盈率30.12
股息0.25	股息收益率0.01	ROA6.82%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":28.45,"timestamp":1753430887003,"preClose":30.4,"halted":0,"volume":104888702,"delay":0,"floatShares":2400000000,"shares":2400000000,"eps":0.9444869323474699,"marketStatus":"已收盘","change":-1.95,"latestTime":"07-25 16:08:07","open":29.35,"high":29.7,"low":27.4,"amount":3002550490,"amplitude":0.075658,"askPrice":28.45,"askSize":27500,"bidPrice":28.4,"bidSize":18500,"shortable":3,"etf":0,"ttmEps":0.930776053563159,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":30.4,"dividendRate":0.008787,"openAndCloseTimeList":[[1753407000000,1753416000000],[1753419600000,1753430400000]],"volumeRatio":2.029407,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530","defaultTab":"news","newsList":[{"id":"2554737204","title":"外资公募二季度持仓策略：聚焦“科技+医药”，增配高股息资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2554737204","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554737204?lang=zh_cn&edition=full","pubTime":"2025-07-25 10:35","pubTimestamp":1753410920,"startTime":"0","endTime":"0","summary":"随着公募基金二季度报告披露收官，贝莱德基金、富达基金、路博迈基金和摩根基金等外资公募机构的持仓策略浮出水面。二季度，部分外资公募旗下绩优产品延续了“科技+医药”的核心配置，同时显著增加了高股息资产的持仓。在科技板块，多只外资公募基金对科技行业的配置比例明显提升。医药生物板块方面，外资公募基金的配置策略发生显著变化，创新药领域成为重点关注对象。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725104057a6c0b201&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725104057a6c0b201&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601398","601288","00939","688981","01530","IDCBY","01288","BK4207","ACGBF","00981","601939","01398"],"gpt_icon":0},{"id":"2554173239","title":"港股异动 | 三生制药(01530)跌超4% 与辉瑞许可协议生效 折让17.09%发新股筹7.85亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554173239","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554173239?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:47","pubTimestamp":1753408074,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药(01530)跌超4%，截至发稿，跌4.44%，报29.05港元，成交额5.25亿港元。消息面上，三生制药公布，公司与辉瑞就PD-1/VEGF双特异性抗体(SSGJ-707)订立的许可协议之所有先决条件已达成，许可协议自7月24日起生效。同日，双方订立认购协议，向辉瑞发行3114.25万股，每股作价25.2055港元，较7月24日收报折让17.09%，总金额约7.85亿港元。完成后，辉瑞将持有公司股本1.28%。所得净额约80%用于丰富产品管线中的临床及临床前项目的全球研发布局，以及改善生产设施；余额拨作一般公司用途。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B19Z3581.USD","LU1066051498.USD","BK1161","LU0234572021.USD","BK4568","SG9999001176.SGD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0225284248.USD","01530","LU0985481810.HKD","LU1057294990.SGD","SG9999003800.SGD","LU0456855351.SGD","LU1883839398.USD","LU1894683264.USD","LU0321505868.SGD","LU1066053197.SGD","BK4599","IE00BLSP4452.SGD","BK4581","LU0122379950.USD","LU1894683348.USD","BK4592","LU0058720904.USD","IE0002270589.USD","BK4585","LU0868494617.USD","IE000M9KFDE8.USD","BK4534","PFE","BK4588","SG9999011175.SGD","BK4533","BK1583","SG9999002232.USD","BK4007","BK4550","LU0306806265.USD","SGXZ57979304.SGD","SG9999001176.USD","SG9999002224.SGD","IE00BLSP4239.USD","LU0170899867.USD","BK1593","LU0225771236.USD","LU0289739699.SGD","LU0321505439.SGD","LU1023059063.AUD","LU0306807586.USD"],"gpt_icon":0},{"id":"1121942381","title":"异动解读 | 三生制药盘中大跌5.1%，拟向辉瑞折价发行新股","url":"https://stock-news.laohu8.com/highlight/detail?id=1121942381","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121942381?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:34","pubTimestamp":1753407276,"startTime":"0","endTime":"0","summary":"三生制药今日盘中大跌5.1%，引发市场关注。根据公司最新公告，这一股价下跌或与其向辉瑞配发新股有关。三生制药于7月24日交易时间后与辉瑞达成协议，拟向后者配发3114.25万股新股，发行价为每股25.2055港元，较公告日收盘价30.40港元折价约17.09%。此次配股将为三生制药筹集约7.85亿港元净额。尽管短期内可能对股价造成压力，但与全球制药巨头辉瑞的战略合作有望为三生制药带来长期发展机遇。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01530"],"gpt_icon":0},{"id":"1186878417","title":"异动解读 | 三生制药发行新股致盘中大跌5.1%，与辉瑞达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1186878417","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186878417?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:34","pubTimestamp":1753407273,"startTime":"0","endTime":"0","summary":"三生制药今日盘中大跌5.1%，引发市场关注。根据公司最新公告，此次股价下跌主要与其向辉瑞发行新股有关。公告显示，三生制药于7月24日与辉瑞达成协议，将向后者定向发行3114.25万股新股，发行价为每股25.2055港元，较协议签署日收盘价30.40港元折价约17.09%。此外，三生制药还宣布与辉瑞就PD-1/VEGF双特异性抗体达成许可协议。尽管此次合作对三生制药长期发展有利，但短期内的股份稀释效应导致股价承压。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01530"],"gpt_icon":0},{"id":"2554364567","title":"差价600亿，这款国产药贱卖了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2554364567","media":"中国新闻周刊","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554364567?lang=zh_cn&edition=full","pubTime":"2025-07-25 07:01","pubTimestamp":1753398093,"startTime":"0","endTime":"0","summary":"2023年10月16日，在2023上海国际生物医药产业周开幕活动中举行的上海市创新药械出海国际合作伙伴计划启航仪式。5月底，三生制药与跨国药企辉瑞达成一项合作，12.5亿美元的首付款刷新了国内创新药海外授权的首付款纪录，大大调动起了二级市场的热情。截至7月16日，恒生港股通创新药精选指数累计上涨近80％。截至目前，和铂医药已完成17次BD出海交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725071241a6c0592c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725071241a6c0592c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688192","02142","01093","01276","688506","01530"],"gpt_icon":0},{"id":"2553005202","title":"三生制药(01530.HK)拟向辉瑞配发3114.25万股 净筹约7.85亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553005202","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553005202?lang=zh_cn&edition=full","pubTime":"2025-07-24 19:29","pubTimestamp":1753356596,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0985481810.HKD","BK4588","LU0225771236.USD","IE00BLSP4452.SGD","LU1066051498.USD","SG9999002232.USD","SG9999013999.USD","LU0234572021.USD","LU0225284248.USD","LU1169590202.USD","SG9999002224.SGD","SG9999001176.SGD","SG9999003800.SGD","SG9999011175.SGD","LU0170899867.USD","LU1057294990.SGD","BK1161","LU0321505868.SGD","LU0058720904.USD","BK4568","LU1894683264.USD","SGXZ57979304.SGD","BK1593","01530","LU1894683348.USD","BK4550","LU0868494617.USD","LU0306806265.USD","BK1583","IE00BBT3K403.USD","SG9999001176.USD","BK4592","LU0306807586.USD","BK4585","BK4581","PD","LU1023059063.AUD","LU0289739699.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU1169589451.USD","BK4599","LU1066053197.SGD","LU1883839398.USD","PFE","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4533","BK4007"],"gpt_icon":0},{"id":"2553479985","title":"基金2季报收官，公募对AI和创新药的“偏爱”，藏都不藏了","url":"https://stock-news.laohu8.com/highlight/detail?id=2553479985","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553479985?lang=zh_cn&edition=full","pubTime":"2025-07-21 18:08","pubTimestamp":1753092480,"startTime":"0","endTime":"0","summary":"来源：华尔街见闻抄底AI和创新药2025年公募基金2季报，日前全部发布完毕。在这个转折的季节，公募基金对A股的偏好和增减仓，态度十分明显。根据WIND对截至7月21日下午4点的发布统计，公募基金年中的十大重仓股中，AI概念股大获追捧。此外，创新药企业也迎来了不少基金经理的“追捧”。尤其值得一提的是，主动公募基金对中际旭创、新易盛的持股总市值，在2季度增长了百亿元以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721193108a4596751&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721193108a4596751&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600519","01810","CVM","00981","ZIJMY","00300","601899","09988","ZIJMF","02899","600760","BK4139","01530","688981","01801","06936","BK4017","03750"],"gpt_icon":0},{"id":"2553842793","title":"葛兰、谢治宇最新持仓曝光：共同聚焦创新药，这些个股被重仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2553842793","media":"每经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553842793?lang=zh_cn&edition=full","pubTime":"2025-07-21 16:56","pubTimestamp":1753088193,"startTime":"0","endTime":"0","summary":"另外，兴证全球基金谢治宇管理的兴全合润，二季度减持了比亚迪、海尔智家，转而重仓分众传媒、蓝思科技。葛兰二季度加码创新药先从中欧医疗健康来看，二季度虽然出现净赎回的情况，但整体份额依然超过185亿份，规模超过300亿元。整体来看，创新药行业的持仓个股数量进一步增加，而多只医疗个股、中药个股已不见身影。可以看出，谢治宇二季度也偏爱创新药，重仓了多只个股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721165943a459004f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721165943a459004f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","81211","600690","01801","03347","688099","06613","09969","BK0188","06690","159992","688235","01530","BK0229","600160","BK0044","03759","BK0015","03750","01211","01415","688428","BYDDY","BK0196"],"gpt_icon":0},{"id":"2553216454","title":"一图速览Q2基金持仓变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2553216454","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553216454?lang=zh_cn&edition=full","pubTime":"2025-07-21 15:46","pubTimestamp":1753083961,"startTime":"0","endTime":"0","summary":"25Q2基金持仓有何变化？","market":"sg","thumbnail":"https://img3.gelonghui.com/0c859-a7b88c71-79a3-4043-b704-e9d2f0cb83af.jpg?guru_height=3339&guru_width=6010&guru_size=899485","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/0c859-a7b88c71-79a3-4043-b704-e9d2f0cb83af.jpg?guru_height=3339&guru_width=6010&guru_size=899485"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2522815","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["HTCD.SI","01530","LU2087589342.USD","LU1152091168.USD","LU1105468828.SGD","LU0149534421.HKD","LU1769817096.USD","LU0254981946.USD","00700","BK1589","ALBmain","LU0149721374.USD","TCHmain","300502","LU2580892789.USD","LU0228367735.SGD","LU0572944931.SGD","LU0106259558.USD","LU0320764755.SGD","LU1725190679.HKD","300308","SG9999006597.SGD","LU1481107354.HKD","LU2251237488.HKD","BABA","LU0449515922.USD","LU0918141887.USD","LU1868838027.USD","LU1044874839.SGD","LU1235294995.USD","09992","LU0165289439.USD","LU0516422952.EUR","LU0106252389.USD","300476","BK4543","002463","LU0455707207.USD","LU0823041008.USD","LU0540923850.HKD","LU0862451753.SGD","LU1956131251.USD","01801","LU0577902298.EUR","LU1568876251.USD","09988","LU1303224171.USD","IE00B543WZ88.USD","LU2008162690.USD","LU1242518931.SGD"],"gpt_icon":1},{"id":"2552419098","title":"中欧基金葛兰二季度加仓科伦药业、三生制药，业绩回暖难挡高份额净赎回","url":"https://stock-news.laohu8.com/highlight/detail?id=2552419098","media":"澎湃新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552419098?lang=zh_cn&edition=full","pubTime":"2025-07-19 16:13","pubTimestamp":1752912780,"startTime":"0","endTime":"0","summary":"中欧基金投资总监葛兰旗下两只医药主题基金再遭高份额净赎回。在调仓换股上，中欧医疗健康在二季度期间的换股动作较为明显，百利天恒、信立泰、百济神州、新诺威新进持仓前十，还增持了科伦药业。但业绩回暖难挡投资者离场，中欧医疗健康在二季度继续遭遇净赎回12.99亿份，已是近一年来最高的赎回份额，也是成立以来次高的净赎回份额，仅低于2024年一季度14.81亿份的净赎回。与此同时，科伦药业获葛兰大幅增持，加仓比例达42.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719163209a6b3a578&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719163209a6b3a578&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1583","BK1161","01530"],"gpt_icon":0},{"id":"2552649161","title":"三生制药07月18日获主力加仓4679.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552649161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552649161?lang=zh_cn&edition=full","pubTime":"2025-07-18 16:15","pubTimestamp":1752826559,"startTime":"0","endTime":"0","summary":"07月18日, 三生制药股价涨2.45%，报收31.35元，成交金额9.7亿元，换手率1.31%，振幅5.72%，量比0.67。三生制药今日主力资金净流入4679.5万元，连续6日净流入，上一交易日主力净流入2.5亿元。近一年数据显示，该股主力连续6日净流入后，次日上涨概率为100.00%，平均涨幅为2.71%。该股近5个交易日上涨24.85%，主力资金累计净流入5.1亿元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入11.0亿元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718172704a6b1ce55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718172704a6b1ce55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","01530","BK1583"],"gpt_icon":0},{"id":"2552486035","title":"重仓泡泡玛特、新易盛、信达生物等多只热门股！永赢基金高楠最新持仓曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486035","media":"中证金牛座","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552486035?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:36","pubTimestamp":1752741360,"startTime":"0","endTime":"0","summary":"7月17日，永赢基金首席权益投资官、权益投资部总经理、知名基金经理高楠旗下公募产品披露了2025年二季报。以其中规模较大的永赢睿信为例，二季度，该基金前十大重仓股为泡泡玛特、中际旭创、康方生物、新易盛、匠心家居、信达生物、潍柴重机、百济神州、三生制药、紫金矿业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071717030997a98de8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071717030997a98de8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0012","BK0242","LU2148510915.USD","BK0028","300502","LU1997245094.SGD","01530","BK0167","601899","01801","BK0188","LU1997244956.HKD","LU1064131003.USD","BK0183","BK0214","BK0132","SGXZ49509284.SGD","LU1064130708.USD","BK0077","LU1997245177.USD","BK0127","LU2289578879.USD","SGXZ81163826.USD","LU2495084118.USD","BK0148","BK0015"],"gpt_icon":0},{"id":"2552058901","title":"创新药再获热炒 恒生医疗ETF涨4.37% 乐普生物(02157)涨两成 机构称价值重估驱动行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2552058901","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552058901?lang=zh_cn&edition=full","pubTime":"2025-07-17 14:08","pubTimestamp":1752732500,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药再获热炒，恒生医疗ETF暂涨4.37%，乐普生物-B 涨20.55%，康诺亚-B涨14.7%，康方生物涨11.75%，三生制药涨11.09%，百济神州涨10.02%，科伦博泰生物-B涨9.29%，金斯瑞生物科技涨8.45%，先声药业涨8.44%。国家医保局于本周二宣布启动第11轮国家药品集采，涉及55种药品。医院需在7月16日至7月31日期间报告采购量。值得注意的是，《通知》首次附上了68种符合评价标准但未纳入第11批VBP的产品名单，并具体说明了排除原因。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962441","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720050803.USD","02162","LU1794554557.SGD","06978","01548","HK0000320264.USD","IE00BPRC5H50.USD","06990","BK1161","LU2488822045.USD","BK1574","06160","LU0588546209.SGD","LU0348784397.USD","LU0417516571.SGD","HK0000306701.USD","LU1969619763.USD","01530","BK1191","BK1583","BK1588","02096","IE00B5MMRT66.SGD","IE00B543WZ88.USD","02157","513060","BK1500","LU0196878994.USD","159992","BK1587","BK1593","HK0000306685.HKD","HK0000320223.HKD","LU0348783233.USD","BK1141","LU2328871848.SGD","BK1576","09926","LU0307460666.USD"],"gpt_icon":0},{"id":"1126684543","title":"港股创新药概念股持续上攻，康方生物等多股创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1126684543","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126684543?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:39","pubTimestamp":1752716365,"startTime":"0","endTime":"0","summary":"7月17日，港股创新药概念股延续强势，$康方生物(09926)$涨超8%，$三生制药(01530)$、$乐普生物-B(02157)$涨超6%，$亚盛医药-B(06855)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4e7834c15c47c74e9bfd4d734ca81974","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","BK4614","LU0417516571.SGD","BK1161","BK1574","LU0348783233.USD","LU1794554557.SGD","BK1583","IE00BPRC5H50.USD","LU1720050803.USD","09926","01530","LU0348784397.USD","LU2488822045.USD","BK1593","09606","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2552317142","title":"三生制药盘中异动 早盘急速拉升5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552317142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552317142?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:34","pubTimestamp":1752716061,"startTime":"0","endTime":"0","summary":"2025年07月17日早盘09时34分，三生制药股票出现波动，股价快速拉升5.55%。截至发稿，该股报29.500港元/股，成交量419.45万股，换手率0.17%，振幅5.19%。三生制药股票所在的药品行业中，整体涨幅为0.06%。其相关个股中，海王英特龙、开拓药业-B、三生制药涨幅较大，振幅较大的相关个股有海王英特龙、开拓药业-B、三生制药，振幅分别为8.18%、7.08%、4.83%。三生制药公司简介：投资控股,及本集团主要在中国从事开发、生产、营销及销售生物医药产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717093422a6ae82e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717093422a6ae82e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01530","BK1583","BK1593"],"gpt_icon":0},{"id":"2552106892","title":"港股医药：板块表现强势 建议积极增加配置","url":"https://stock-news.laohu8.com/highlight/detail?id=2552106892","media":"光大证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552106892?lang=zh_cn&edition=full","pubTime":"2025-07-17 00:00","pubTimestamp":1752681600,"startTime":"0","endTime":"0","summary":"年初至今恒生医疗保健指数表现靓丽。关注盈利改善和BD 交易的实质性进展机会，建议积极增加板块配置。港股医药板块估值收缩已持续数年，部分优质企业PE 估值在反弹后仍具吸引力。考虑到部分创新药公司BD 交易持续催化、细分赛道及正处于转型阶段的公司或有积极变化，我们认为应当积极关注板块高质量标的、增加板块配置。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717141220a4504a5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717141220a4504a5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00853","01093","BK1589","00867","01066","01530","01177","BK1583","BK1585","BK1100"],"gpt_icon":0},{"id":"2551141731","title":"上半年20起大型药企与中国创新药公司交易！","url":"https://stock-news.laohu8.com/highlight/detail?id=2551141731","media":"创鉴汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551141731?lang=zh_cn&edition=full","pubTime":"2025-07-16 17:08","pubTimestamp":1752656931,"startTime":"0","endTime":"0","summary":"2025年上半年，大型药企与中国创新药公司之间的交易活动活跃度提高，反映出中国在全球创新药领域的快速崛起和强大吸引力。根据创鉴汇不完全统计，上半年中国创新药企与大型药企共达成20笔交易，披露的交易潜在总金额近300亿美元，其中单笔最高达60.5亿美元，显示出大型药企对中国创新药的高度信心。协议包括首付款8000万美元，潜在交易总额20.1亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716174021a44e69e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716174021a44e69e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2417539215.USD","BK4581","LU0321505439.SGD","LU0306806265.USD","LU0170899867.USD","SG9999011175.SGD","LU1883839398.USD","SGXZ57979304.SGD","LU0122379950.USD","LU0321505868.SGD","AZN","BK4585","BK4534","LU0456855351.SGD","LU0868494617.USD","MRK","LU2456880835.USD","BK4588","LU2462157665.USD","LU0225284248.USD","SG9999002232.USD","LU1894683264.USD","IE0002270589.USD","LU0234572021.USD","LU0985481810.HKD","BK4599","03692","BK4080","IE00BLSP4452.SGD","SG9999001176.SGD","IE00BLSP4239.USD","01093","LU1894683348.USD","ORR","LU1066051498.USD","PFE","IE00B19Z3581.USD","BK4592","SG9999002224.SGD","IE000M9KFDE8.USD","LU2236285917.USD","ADC","BK4007","01530","LU0109394709.USD","SG9999003800.SGD","BK4550","LU0889565916.HKD","IE00BBT3K403.USD","LU0306807586.USD","SG9999001176.USD","MSD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2551712143","title":"每日卖空追踪 | 三生制药 07月16日卖空量成交213.1万股，卖空比例为7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551712143","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551712143?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:30","pubTimestamp":1752654625,"startTime":"0","endTime":"0","summary":"三生制药北京时间07月16日，跌2.27%，卖空量成交213.1万股%，较上一交易日减少59.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716172408a6ad1ff0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716172408a6ad1ff0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","01530","BK1583"],"gpt_icon":0},{"id":"2551145275","title":"中证香港200动量指数报3794.56点，前十大权重包含中信证券等","url":"https://stock-news.laohu8.com/highlight/detail?id=2551145275","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551145275?lang=zh_cn&edition=full","pubTime":"2025-07-16 15:49","pubTimestamp":1752652178,"startTime":"0","endTime":"0","summary":"数据统计显示，中证香港200动量指数近一个月上涨8.37%，近三个月上涨28.68%，年至今上涨33.00%。从中证香港200动量指数持仓的市场板块来看，香港证券交易所占比100.00%。从中证香港200动量指数持仓样本的行业来看，医药卫生占比19.26%、金融占比19.22%、信息技术占比13.05%、通信服务占比10.99%、可选消费占比9.80%、工业占比8.52%、原材料占比6.84%、主要消费占比5.29%、公用事业占比3.69%、房地产占比3.33%。特殊情况下将对中证香港策略指数系列进行临时调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071615561797a82884&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071615561797a82884&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1794554557.SGD","IE00BHRH8C09.USD","LU0823413587.USD","00788","IE00BHRH8D16.HKD","BK1133","IE00BG0RBZ43.SGD","LU1720050803.USD","BK1564","BK1506","LU0823413660.USD","BK1583","00268","BK1516","BK1147","BK1529","06030","01530","BK1589","BK1521","09926"],"gpt_icon":0},{"id":"2551150073","title":"三生制药07月15日获主力加仓1286.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551150073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551150073?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:15","pubTimestamp":1752567355,"startTime":"0","endTime":"0","summary":"07月15日, 三生制药股价涨1.42%，报收28.60元，成交金额11.0亿元，换手率1.64%，振幅7.62%，量比1.03。三生制药今日主力资金净流入1286.4万元，连续3日净流入，上一交易日主力净流入1.9亿元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为50.00%，平均涨幅为5.91%。该股近5个交易日上涨16.09%，主力资金累计净流入3.1亿元；近20日主力资金累计净流入8.1亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715165747a6aab936&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715165747a6aab936&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","01530","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":0.353},{"period":"3month","weight":1.3537},{"period":"6month","weight":3.991},{"period":"1year","weight":3.8408},{"period":"ytd","weight":4.0398}],"compareEarnings":[{"period":"1week","weight":0.0477},{"period":"1month","weight":0.0616},{"period":"3month","weight":0.1677},{"period":"6month","weight":0.2791},{"period":"1year","weight":0.4827},{"period":"ytd","weight":0.2795}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3SBio Inc是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司。该公司的主要产品包括特比澳、益比奥、益赛普、赛普汀等生物药物以及蔓迪、丽美治等小分子药物。该公司还从事为客户提供多种生物药的研发生产以及治疗技术平台服务的合同开发与生产运营（CDMO）业务。该公司的产品主要应用于血小板减少症（CIT）、慢性肾病（CKD）引起的贫血症、治疗化疗引起的贫血症（CIA）、强直性嵴柱炎（AS）及银屑病等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003687},{"month":2,"riseRate":0.5,"avgChangeRate":0.007795},{"month":3,"riseRate":0.8,"avgChangeRate":0.121345},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014398},{"month":5,"riseRate":0.7,"avgChangeRate":0.109101},{"month":6,"riseRate":0.8,"avgChangeRate":0.036581},{"month":7,"riseRate":0.090909,"avgChangeRate":-0.044841},{"month":8,"riseRate":0.4,"avgChangeRate":-0.006266},{"month":9,"riseRate":0.6,"avgChangeRate":0.02732},{"month":10,"riseRate":0.4,"avgChangeRate":-0.022805},{"month":11,"riseRate":0.7,"avgChangeRate":0.064411},{"month":12,"riseRate":0.5,"avgChangeRate":-0.027207}],"exchange":"SEHK","name":"三生制药","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生制药,01530,三生制药股票,三生制药股票老虎,三生制药股票老虎国际,三生制药行情,三生制药股票行情,三生制药股价,三生制药股市,三生制药股票价格,三生制药股票交易,三生制药股票购买,三生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}